bOPV,bivalent type 1+3,vial of 20 doses

Oral Polio Vaccine, bivalent (OPV type 1 and 3)vial of 20 doses.
Indicative Price 2.82 USD
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

General Description:
Oral Polio Vaccine, bivalent, (OPV type 1 and 3), vial of 20 doses

Poliomyelitis vaccine, live, oral, bivalent, 20 dose presentation; ready for use either in vial with dropper or in the form of dispenser, with vaccine vial monitor (VVM) affixed on to individual vial/dispenser. It is a bivalent vaccine containing suspension of type 1 and 3 attenuated poliomyelitis virus (Sabin strain).

For information on product specifications, refer to the WHO website on Prequalified Vaccines.
Click here

http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_lis t_en/en/index.html

bOPV must only be administered orally. Two drops are delivered directly into the mouth from the multi-dose vial by dropper or dispenser. Care should be taken not to contaminate a multi-dose dropper with saliva of the vaccine.

Once opened, multi-dose vials should be stored under appropriate cold chain conditions (as recommended by the manufacturer). Multi-dose vials of bOPV from which one or more doses of vaccine have been removed during an immunization session may be used in subsequent immunization sessions for up to a maximum of 4 weeks, provided that all of the following conditions are met (as described in the WHO policy statement: The use of opened multi-dose vials in subsequent immunization sessions.

The expiry date has not passed;
The vaccines are stored under appropriate cold chain conditions;
The vaccine vial septum has not been submerged in water;
Aseptic technique has been used to withdraw all doses;
The vaccine vial monitor (VVM) has not reached the discard point.

Immunization Schedule:
Bivalent Types 1 & 3 Oral Poliomyelitis Vaccine is indicated for poliomyelitis Supplementary Immunization Activities (SIAs) in children from 0 to 5 years of age, to interrupt types 1 & 3 poliovirus transmission in remaining polio endemic areas. The routine poliomyelitis vaccination programme should continue to use trivalent vaccines according to national policy.

Transport and Storage:
Vaccine is potent if stored at not higher than -20°C until the expiry date indicated on the vial. It can be stored for up to six months between +2°C and +8°C. The vaccine supplied in plastic tubes may change colour due to storage with dry ice; however this does not affect the quality of the vaccine.

Related Products